Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 115

1.

Office-Based Point of Care Testing (IgA/IgG-Deamidated Gliadin Peptide) for Celiac Disease.

Lau MS, Mooney PD, White WL, Rees MA, Wong SH, Hadjivassiliou M, Green PHR, Lebwohl B, Sanders DS.

Am J Gastroenterol. 2018 Jun 19. doi: 10.1038/s41395-018-0143-3. [Epub ahead of print]

PMID:
29915400
2.

Lower gastrointestinal symptoms are associated with worse glycemic control and quality of life in type 1 diabetes mellitus.

Leeds JS, Hadjivassiliou M, Tesfaye S, Sanders DS.

BMJ Open Diabetes Res Care. 2018 May 29;6(1):e000514. doi: 10.1136/bmjdrc-2018-000514. eCollection 2018.

3.

Quality of Life in Patients with Gluten Neuropathy: A Case-Controlled Study.

Zis P, Sarrigiannis PG, Rao DG, Hadjivassiliou M.

Nutrients. 2018 May 23;10(6). pii: E662. doi: 10.3390/nu10060662.

4.

Sensory neuropathic symptoms in idiopathic Parkinson's disease: prevalence and impact on quality of life.

Adewusi JK, Hadjivassiliou M, Vinagre-Aragón A, O'Connor KR, Khan A, Grünewald RA, Zis P.

Acta Neurol Belg. 2018 May 23. doi: 10.1007/s13760-018-0947-3. [Epub ahead of print]

PMID:
29796943
5.

Exaggerated startle in post-infectious opsoclonus myoclonus syndrome.

Blackburn DJ, Forbes M, Unwin Z, Hoggard N, Hadjivassiliou M, Sarrigiannis PG.

Clin Neurophysiol. 2018 Jul;129(7):1372-1373. doi: 10.1016/j.clinph.2018.03.026. Epub 2018 Apr 13. No abstract available.

PMID:
29729591
6.

Nocebo in chronic inflammatory demyelinating polyneuropathy; a systematic review and meta-analysis of placebo-controlled clinical trials.

Zis P, Hadjivassiliou M, Sarrigiannis PG, Jenkins TM, Mitsikostas DD.

J Neurol Sci. 2018 May 15;388:79-83. doi: 10.1016/j.jns.2018.03.009. Epub 2018 Mar 7.

PMID:
29627036
7.

Axillary motor nerve conduction study: Description of technique and provision of normative data.

Zis P, Hadjivassiliou M, Rao DG.

J Electromyogr Kinesiol. 2018 Apr;39:95-98. doi: 10.1016/j.jelekin.2018.02.002. Epub 2018 Feb 10.

PMID:
29471183
8.

Phenytoin-related ataxia in patients with epilepsy: clinical and radiological characteristics.

Shanmugarajah PD, Hoggard N, Aeschlimann DP, Aeschlimann PC, Dennis GJ, Howell SJ, Reuber M, Grünewald RA, Hadjivassiliou M.

Seizure. 2018 Mar;56:26-30. doi: 10.1016/j.seizure.2018.01.019. Epub 2018 Feb 2.

PMID:
29427835
9.

The cortical focus in childhood absence epilepsy; evidence from nonlinear analysis of scalp EEG recordings.

Sarrigiannis PG, Zhao Y, He F, Billings SA, Baster K, Rittey C, Yianni J, Zis P, Wei H, Hadjivassiliou M, Grünewald R.

Clin Neurophysiol. 2018 Mar;129(3):602-617. doi: 10.1016/j.clinph.2017.11.029. Epub 2018 Jan 8.

PMID:
29414404
10.

Rapid neurophysiological screening for sensory ganglionopathy: A novel approach.

Zis P, Hadjivassiliou M, Sarrigiannis PG, Barker ASJE, Rao DG.

Brain Behav. 2017 Nov 24;7(12):e00880. doi: 10.1002/brb3.880. eCollection 2017 Dec.

11.

Cerebellar ataxia with sensory ganglionopathy; does autoimmunity have a role to play?

Zis P, Sarrigiannis PG, Rao DG, Hoggard N, Sanders DS, Hadjivassiliou M.

Cerebellum Ataxias. 2017 Dec 22;4:20. doi: 10.1186/s40673-017-0079-1. eCollection 2017.

12.

Advances in Therapies of Cerebellar Disorders: Immune-mediated Ataxias.

Hadjivassiliou M.

CNS Neurol Disord Drug Targets. 2017 Dec 20. doi: 10.2174/1871527317666171221110548. [Epub ahead of print]

PMID:
29268693
13.

The Overlapping Area of Non-Celiac Gluten Sensitivity (NCGS) and Wheat-Sensitive Irritable Bowel Syndrome (IBS): An Update.

Catassi C, Alaedini A, Bojarski C, Bonaz B, Bouma G, Carroccio A, Castillejo G, De Magistris L, Dieterich W, Di Liberto D, Elli L, Fasano A, Hadjivassiliou M, Kurien M, Lionetti E, Mulder CJ, Rostami K, Sapone A, Scherf K, Schuppan D, Trott N, Volta U, Zevallos V, Zopf Y, Sanders DS.

Nutrients. 2017 Nov 21;9(11). pii: E1268. doi: 10.3390/nu9111268. Review.

14.

Anti-MAG associated cerebellar ataxia and response to rituximab.

Zis P, Rao DG, Hoggard N, Sarrigiannis PG, Hadjivassiliou M.

J Neurol. 2018 Jan;265(1):115-118. doi: 10.1007/s00415-017-8675-9. Epub 2017 Nov 20.

PMID:
29159464
15.

The Role of an IgA/IgG-Deamidated Gliadin Peptide Point-of-Care Test in Predicting Persistent Villous Atrophy in Patients With Celiac Disease on a Gluten-Free Diet.

Lau MS, Mooney PD, White WL, Rees MA, Wong SH, Kurien M, Trott N, Leffler DA, Hadjivassiliou M, Sanders DS.

Am J Gastroenterol. 2017 Dec;112(12):1859-1867. doi: 10.1038/ajg.2017.357. Epub 2017 Oct 10.

PMID:
29016564
16.

Gordon Holmes syndrome: finally genotype meets phenotype.

Mehmood S, Hoggard N, Hadjivassiliou M.

Pract Neurol. 2017 Dec;17(6):476-478. doi: 10.1136/practneurol-2017-001674. Epub 2017 Sep 28.

PMID:
28972031
17.

Mutations in TGM6 induce the unfolded protein response in SCA35.

Tripathy D, Vignoli B, Ramesh N, Polanco MJ, Coutelier M, Stephen CD, Canossa M, Monin ML, Aeschlimann P, Turberville S, Aeschlimann D, Schmahmann JD, Hadjivassiliou M, Durr A, Pandey UB, Pennuto M, Basso M.

Hum Mol Genet. 2017 Oct 1;26(19):3749-3762. doi: 10.1093/hmg/ddx259.

PMID:
28934387
18.

Transglutaminase 6 antibodies in gluten neuropathy.

Zis P, Rao DG, Sarrigiannis PG, Aeschlimann P, Aeschlimann DP, Sanders D, Grünewald RA, Hadjivassiliou M.

Dig Liver Dis. 2017 Nov;49(11):1196-1200. doi: 10.1016/j.dld.2017.08.019. Epub 2017 Aug 10.

PMID:
28886934
19.

Novel POLG variants associated with late-onset de novo status epilepticus and progressive ataxia.

Ng YS, Powell H, Hoggard N, Turnbull DM, Taylor RW, Hadjivassiliou M.

Neurol Genet. 2017 Aug 9;3(5):e181. doi: 10.1212/NXG.0000000000000181. eCollection 2017 Oct. No abstract available.

20.

Effect of gluten-free diet on cerebellar MR spectroscopy in gluten ataxia.

Hadjivassiliou M, Grünewald RA, Sanders DS, Shanmugarajah P, Hoggard N.

Neurology. 2017 Aug 15;89(7):705-709. doi: 10.1212/WNL.0000000000004237. Epub 2017 Jul 19.

PMID:
28724585

Supplemental Content

Loading ...
Support Center